Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Waters Co. (NYSE:WAT - Free Report) by 4.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,649 shares of the medical instruments supplier's stock after acquiring an additional 1,261 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned 0.05% of Waters worth $11,741,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Bank of Jackson Hole Trust bought a new position in shares of Waters in the fourth quarter worth about $34,000. Ashton Thomas Securities LLC bought a new position in shares of Waters in the third quarter worth about $35,000. Fortitude Family Office LLC boosted its stake in shares of Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 66 shares during the period. Steward Partners Investment Advisory LLC boosted its stake in shares of Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 53 shares during the period. Finally, R Squared Ltd bought a new position in shares of Waters in the fourth quarter worth about $63,000. Institutional investors own 94.01% of the company's stock.
Waters Stock Up 3.8 %
NYSE WAT traded up $13.74 during midday trading on Friday, hitting $378.18. 378,958 shares of the company traded hands, compared to its average volume of 437,672. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The company has a market cap of $22.47 billion, a PE ratio of 35.31, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00. The company's 50-day simple moving average is $391.24 and its 200-day simple moving average is $370.28. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56.
Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. As a group, equities research analysts forecast that Waters Co. will post 12.86 earnings per share for the current year.
Analyst Ratings Changes
A number of equities research analysts recently commented on the company. Scotiabank upgraded Waters from a "sector perform" rating to a "sector outperform" rating and boosted their target price for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. JPMorgan Chase & Co. boosted their target price on Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a research report on Thursday, March 6th. Wells Fargo & Company boosted their target price on Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Barclays upgraded Waters from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. Finally, Bank of America decreased their target price on Waters from $430.00 to $410.00 and set a "neutral" rating on the stock in a research report on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $391.07.
Read Our Latest Research Report on Waters
Waters Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
